Status:
COMPLETED
Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Migraine
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This study will evaluate the comparative bioavailability of three capsule formulations of MK-0974.
Eligibility Criteria
Inclusion
- Subject is in good health
- Subject is a nonsmoker
- Subject is willing to comply with the study restrictions
Exclusion
- Subject has a history of stroke, chronic seizures, or major neurological disorder
- Subject has a history of cancer
- Subject is a nursing mother
- Subject has or has a history of any illness that might make participation in the study unsafe or confound the results of the study
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01209741
Start Date
October 1 2007
End Date
November 1 2007
Last Update
August 18 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.